AI assistant
Episurf Board/Management Information 2025
3157_rns_2025-05-16_0224810b-c304-4dbb-bc7f-fc3f0aca9973.pdf
Board/Management Information
Open in viewerOpens in your device viewer
Pål Ryfors appointed interim CFO of Episurf Medical
Episurf Medical AB (publ) announces that the company's CEO, Pål Ryfors, has been appointed interim CFO as of 19 May 2025 in addition to his current role as CEO. This follows the departure of Veronica Wallin from her position as CFO, as previously communicated. The recruitment process for a new CFO is ongoing.
For more information, please contact:
Pål Ryfors, CEO, Episurf Medical Tel:+46 (0) 709 62 36 69 Email: [email protected]
About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical's Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical's μiFidelity® system enables implants to be costefficiently tailored to each individual's unique injury for the optimal fit and minimal intervention. Episurf Medical's head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company's website: www.episurf.com.
The information was submitted for publication, through the agency of the contact person set out above, at 10.00 CEST on 16 May 2025.